Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.GE Healthcare will invest $1bn over the next five years to broaden its advanced cancer diagnostic, molecular imaging capabilities and its technologies to manufacture biopharmaceuticals and also for cancer research.
Subscribe to our email newsletter
GE Healthcare vice president and CTO Mike Harsh said the only way they can facilitate clinicians to eradicate cancer is to provide them the tools to find it earlier, stage it better, and quantitatively measure response to therapy.
"The integration of GE Healthcare’s expertise in imaging, analytics, diagnostics, cellular analysis, and healthcare IT is helping create technologies and solutions that can be used in a rural developing country or in a modern urban hospital," Harsh said.
GE Healthcare will use the investment to develop new oncology solutions and advanced technologies and to perform research in some areas which are already in progress including new biomarkers, cancer research, connected oncology workflow, hyperpolarizer, molecular pathology.